annual operating profit:
-$50.41M-$4.34M(-9.42%)Summary
- As of today (June 29, 2025), AKBA annual operating income is -$50.41 million, with the most recent change of -$4.34 million (-9.42%) on December 31, 2024.
- During the last 3 years, AKBA annual operating profit has risen by +$214.09 million (+80.94%).
- AKBA annual operating profit is now -491.51% below its all-time high of -$8.52 million, reached on December 31, 2012.
Performance
AKBA Operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating profit:
$13.51M+$27.82M(+194.46%)Summary
- As of today (June 29, 2025), AKBA quarterly operating income is $13.51 million, with the most recent change of +$27.82 million (+194.46%) on March 31, 2025.
- Over the past year, AKBA quarterly operating profit has increased by +$28.39 million (+190.83%).
- AKBA quarterly operating profit is now -72.20% below its all-time high of $48.61 million, reached on June 30, 2022.
Performance
AKBA quarterly operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM operating profit:
-$22.02M+$28.39M(+56.32%)Summary
- As of today (June 29, 2025), AKBA TTM operating income is -$22.02 million, with the most recent change of +$28.39 million (+56.32%) on March 31, 2025.
- Over the past year, AKBA TTM operating profit has increased by +$13.44 million (+37.90%).
- AKBA TTM operating profit is now -754.70% below its all-time high of -$2.58 million, reached on March 31, 2013.
Performance
AKBA TTM operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating profit Formula
Operating Profit = Gross Profit − Operating Expenses
AKBA Operating profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -9.4% | +190.8% | +37.9% |
| 3 y3 years | +80.9% | +123.1% | +91.5% |
| 5 y5 years | +82.4% | +122.9% | +91.8% |
AKBA Operating profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -9.4% | +80.9% | -72.2% | +123.1% | at high | +91.5% |
| 5 y | 5-year | -9.4% | +86.7% | -72.2% | +107.8% | at high | +94.3% |
| alltime | all time | -491.5% | +86.7% | -72.2% | +107.8% | -754.7% | +94.3% |
AKBA Operating profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $13.51M(-194.5%) | -$22.02M(-56.3%) |
| Dec 2024 | -$50.41M(+9.4%) | -$14.31M(+14.4%) | -$50.41M(+45.1%) |
| Sep 2024 | - | -$12.51M(+43.3%) | -$34.73M(-1.0%) |
| Jun 2024 | - | -$8.72M(-41.4%) | -$35.10M(-1.0%) |
| Mar 2024 | - | -$14.88M(-1182.8%) | -$35.46M(-23.0%) |
| Dec 2023 | -$46.08M(-28.9%) | $1.37M(-110.7%) | -$46.07M(-9.8%) |
| Sep 2023 | - | -$12.87M(+41.6%) | -$51.09M(-42.2%) |
| Jun 2023 | - | -$9.09M(-64.3%) | -$88.45M(+187.6%) |
| Mar 2023 | - | -$25.49M(+599.0%) | -$30.76M(-51.8%) |
| Dec 2022 | -$64.85M(-75.5%) | -$3.65M(-92.7%) | -$63.76M(-49.2%) |
| Sep 2022 | - | -$50.23M(-203.3%) | -$125.45M(-3.6%) |
| Jun 2022 | - | $48.61M(-183.1%) | -$130.11M(-49.6%) |
| Mar 2022 | - | -$58.49M(-10.5%) | -$258.06M(-2.4%) |
| Dec 2021 | -$264.50M(-30.0%) | -$65.34M(+19.0%) | -$264.50M(-7.5%) |
| Sep 2021 | - | -$54.89M(-30.8%) | -$285.95M(-1.1%) |
| Jun 2021 | - | -$79.34M(+22.2%) | -$289.16M(-24.6%) |
| Mar 2021 | - | -$64.94M(-25.2%) | -$383.64M(+1.5%) |
| Dec 2020 | -$377.83M(+32.0%) | -$86.79M(+49.4%) | -$377.83M(-2.1%) |
| Sep 2020 | - | -$58.09M(-66.6%) | -$385.93M(+0.6%) |
| Jun 2020 | - | -$173.82M(+194.0%) | -$383.74M(+42.4%) |
| Mar 2020 | - | -$59.13M(-37.7%) | -$269.44M(-5.9%) |
| Dec 2019 | -$286.29M(+60.7%) | -$94.89M(+69.7%) | -$286.29M(+1.7%) |
| Sep 2019 | - | -$55.91M(-6.1%) | -$281.56M(+11.1%) |
| Jun 2019 | - | -$59.52M(-21.6%) | -$253.49M(+10.4%) |
| Mar 2019 | - | -$75.97M(-15.7%) | -$229.63M(+28.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$178.16M(+132.4%) | -$90.16M(+223.8%) | -$178.16M(+142.7%) |
| Sep 2018 | - | -$27.84M(-21.9%) | -$73.39M(+5.3%) |
| Jun 2018 | - | -$35.66M(+45.6%) | -$69.73M(+24.1%) |
| Mar 2018 | - | -$24.50M(-267.7%) | -$56.20M(-26.7%) |
| Dec 2017 | -$76.67M(-43.8%) | $14.61M(-160.4%) | -$76.67M(-40.7%) |
| Sep 2017 | - | -$24.18M(+9.2%) | -$129.33M(-8.5%) |
| Jun 2017 | - | -$22.14M(-50.8%) | -$141.33M(-9.0%) |
| Mar 2017 | - | -$44.97M(+18.2%) | -$155.39M(+13.9%) |
| Dec 2016 | -$136.46M(+121.8%) | -$38.04M(+5.1%) | -$136.46M(+15.2%) |
| Sep 2016 | - | -$36.18M(-0.0%) | -$118.47M(+16.2%) |
| Jun 2016 | - | -$36.19M(+38.9%) | -$101.96M(+33.0%) |
| Mar 2016 | - | -$26.05M(+29.9%) | -$76.66M(+24.6%) |
| Dec 2015 | -$61.51M(+62.1%) | -$20.05M(+1.9%) | -$61.51M(+18.1%) |
| Sep 2015 | - | -$19.68M(+80.7%) | -$52.07M(+24.0%) |
| Jun 2015 | - | -$10.89M(-0.1%) | -$41.98M(+7.8%) |
| Mar 2015 | - | -$10.90M(+2.7%) | -$38.93M(+2.6%) |
| Dec 2014 | -$37.94M(+138.1%) | -$10.61M(+10.7%) | -$37.94M(+13.1%) |
| Sep 2014 | - | -$9.58M(+22.2%) | -$33.53M(+19.8%) |
| Jun 2014 | - | -$7.84M(-20.9%) | -$27.98M(+20.3%) |
| Mar 2014 | - | -$9.91M(+59.8%) | -$23.26M(+46.0%) |
| Dec 2013 | -$15.93M(+86.9%) | -$6.20M(+53.7%) | -$15.93M(+63.7%) |
| Sep 2013 | - | -$4.03M(+29.3%) | -$9.73M(+70.8%) |
| Jun 2013 | - | -$3.12M(+21.1%) | -$5.70M(+121.1%) |
| Mar 2013 | - | -$2.58M | -$2.58M |
| Dec 2012 | -$8.52M | - | - |
FAQ
- What is Akebia Therapeutics annual operating income?
- What is the all time high annual operating profit for Akebia Therapeutics?
- What is Akebia Therapeutics annual operating profit year-on-year change?
- What is Akebia Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Akebia Therapeutics?
- What is Akebia Therapeutics quarterly operating profit year-on-year change?
- What is Akebia Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Akebia Therapeutics?
- What is Akebia Therapeutics TTM operating profit year-on-year change?
What is Akebia Therapeutics annual operating income?
The current annual operating profit of AKBA is -$50.41M
What is the all time high annual operating profit for Akebia Therapeutics?
Akebia Therapeutics all-time high annual operating income is -$8.52M
What is Akebia Therapeutics annual operating profit year-on-year change?
Over the past year, AKBA annual operating income has changed by -$4.34M (-9.42%)
What is Akebia Therapeutics quarterly operating income?
The current quarterly operating profit of AKBA is $13.51M
What is the all time high quarterly operating profit for Akebia Therapeutics?
Akebia Therapeutics all-time high quarterly operating income is $48.61M
What is Akebia Therapeutics quarterly operating profit year-on-year change?
Over the past year, AKBA quarterly operating income has changed by +$28.39M (+190.83%)
What is Akebia Therapeutics TTM operating income?
The current TTM operating profit of AKBA is -$22.02M
What is the all time high TTM operating profit for Akebia Therapeutics?
Akebia Therapeutics all-time high TTM operating income is -$2.58M
What is Akebia Therapeutics TTM operating profit year-on-year change?
Over the past year, AKBA TTM operating income has changed by +$13.44M (+37.90%)